Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
Although patients with cirrhosis are known to be in a state of “rebalance” in that pro- and anticoagulant factors increase the risk for both bleeding and thrombosis, the prevalence of portal vein thrombosis (PVT) in patients with cirrhosis can be up to 26%. Therefore, physicians should consider anti...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Korean Association for the Study of the Liver
2021-10-01
|
| Serie: | Clinical and Molecular Hepatology |
| Soggetti: | |
| Accesso online: | http://e-cmh.org/upload/pdf/cmh-2021-0109.pdf |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|